Michael Clay Majors Sells 37,000 Shares of Globe Life (NYSE:GL) Stock

Posted by Geri Gentry on Jul 30th, 2026

Globe Life Inc. (NYSE:GL – Get Free Report) EVP Michael Clay Majors sold 37,000 shares of the stock in a transaction that occurred on Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the sale, the executive vice president owned 53,518 shares in the company, valued at approximately $9,560,455.52. The trade was a 40.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Globe Life Trading Up 1.7%

Globe Life stock traded up $2.96 during mid-day trading on Thursday, hitting $182.65. The company’s stock had a trading volume of 759,810 shares, compared to its average volume of 566,665. The company has a 50 day moving average of $170.49 and a 200-day moving average of $153.78. The stock has a market cap of $14.18 billion, a PE ratio of 12.13 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07. Globe Life Inc. has a one year low of $127.85 and a one year high of $191.55.

Globe Life (NYSE:GL – Get Free Report) last released its earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share for the quarter, missing the consensus estimate of $3.67 by ($0.06). Globe Life had a return on equity of 20.73% and a net margin of 19.58%.The business had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same quarter last year, the business posted $3.05 earnings per share. The firm’s revenue for the quarter was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, research analysts anticipate that Globe Life Inc. will post 15.73 EPS for the current year.

Institutional Investors Weigh In On Globe Life

Large investors have recently modified their holdings of the business. Vanguard Group Inc. increased its holdings in Globe Life by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 10,090,885 shares of the company’s stock valued at $1,411,311,000 after buying an additional 86,349 shares during the period. Invesco Ltd. lifted its stake in shares of Globe Life by 2.7% during the 4th quarter. Invesco Ltd. now owns 3,948,676 shares of the company’s stock worth $552,262,000 after purchasing an additional 102,445 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in Globe Life by 10.2% during the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company’s stock valued at $327,479,000 after purchasing an additional 217,331 shares in the last quarter. Morgan Stanley grew its stake in Globe Life by 7.2% in the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after purchasing an additional 125,567 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in shares of Globe Life by 32.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,435,247 shares of the company’s stock valued at $200,734,000 after buying an additional 355,399 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Truist Financial lifted their price objective on shares of Globe Life from $180.00 to $185.00 and gave the company a “buy” rating in a report on Friday, April 24th. Keefe, Bruyette & Woods dropped their target price on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a research note on Friday, July 24th. TD Cowen raised their target price on shares of Globe Life from $215.00 to $225.00 and gave the stock a “buy” rating in a research report on Wednesday, July 22nd. Morgan Stanley lifted their price target on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Finally, Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $191.67.

Get Our Latest Stock Report on Globe Life

Globe Life Company Profile

(Get Free Report)

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.